ConductScience.org, home

Paper · 42258564

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128218905Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.Oncogene2017https://conductscience.org/library/papers/28218905PubMed
227184417Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Nat Rev Clin Oncol2016https://conductscience.org/library/papers/27184417PubMed
332444850Visualizing and interpreting cancer genomics data via the Xena platform.Nat Biotechnol2020https://conductscience.org/library/papers/32444850PubMed
428129544Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.Cell2017https://conductscience.org/library/papers/28129544PubMed
533512556Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.Cancer Immunol Immunother2021https://conductscience.org/library/papers/33512556PubMed
618579285Anoikis resistance and tumor metastasis.Cancer Lett2008https://conductscience.org/library/papers/18579285PubMed
725887482Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.Breast Cancer Res2015https://conductscience.org/library/papers/25887482PubMed
834793275Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond.Expert Opin Investig Drugs2022https://conductscience.org/library/papers/34793275PubMed
932934733Monascin accelerates anoikis in circulating tumor cells and prevents breast cancer metastasis.Oncol Lett2020https://conductscience.org/library/papers/32934733PubMed
1031095287
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.
Ann Oncol2019https://conductscience.org/library/papers/31095287PubMed
1127260936Single-Cell RNA-Seq Steps Up to the Growth Plate.Trends Biotechnol2016https://conductscience.org/library/papers/27260936PubMed
1229130882Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.Elife2017https://conductscience.org/library/papers/29130882PubMed
1327915969Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.Crit Rev Oncog2016https://conductscience.org/library/papers/27915969PubMed
1431056702
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Ann Oncol2019https://conductscience.org/library/papers/31056702PubMed
1538868713Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.Imeta2022https://conductscience.org/library/papers/38868713PubMed
1630345906Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.N Engl J Med2018https://conductscience.org/library/papers/30345906PubMed
1726363006A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.Cancer Res2015https://conductscience.org/library/papers/26363006PubMed
1834336660CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.Front Oncol2021https://conductscience.org/library/papers/34336660PubMed
1938605910Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer.Phenomics2024https://conductscience.org/library/papers/38605910PubMed
2031154235Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review.Crit Rev Oncol Hematol2019https://conductscience.org/library/papers/31154235PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/42258564/references